Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Anticancer Research|May 7, 2017
Impact of Therapy Sequence with Alkylating Agents and MGMT Status in Patients with Advanced Neuroendocrine TumorsSebastian Krug, Michael Boch, Peter Rexin, et al.BMC Research Notes|June 29, 2016
Acromegaly in a patient with a pulmonary neuroendocrine tumor: case report and review of current literatureSebastian Krug, Michael Boch, Peter Rexin, et al.Plos One|December 3, 2015
Streptozocin-Based Chemotherapy in Patients with Advanced Neuroendocrine Neoplasms--Predictive and Prognostic Markers for Treatment StratificationSebastian Krug, Michael Boch, Hanna Daniel, et al.BMC Cancer|September 24, 2014
Paraneoplastic brainstem encephalitis in a patient with exceptionally long course of a metastasized neuroendocrine rectum neoplasmMichael Boch, Anja Rinke, Peter Rexin, et al.British Journal of Clinical Pharmacology|May 6, 2026
Increasing the reporting of adverse drug reaction-related hospitalizations using an ICD-10-based identification workflow: A multicentre study from SwitzerlandGeorgia Anita Weber, Sophie-Charlotte Bartel, Michael Boch, et al.Endocrine-Related Cancer|September 25, 2014
CUX1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasmsSebastian Krug, Benjamin Kühnemuth, Heidi Griesmann, et al.Pageof 1